5 Healthcare Stocks to Buy for Your Portfolio; Recommended by HSBC

Synopsis: HSBC sees steady Q4FY26 growth in Apollo Hospitals, Max Healthcare Institute, Aster DM Healthcare, KIMS, and Rainbow Childrens Medicare, driven by elective procedures, with Apollo Hospitals as its top pick.

HSBC remains positive on the hospital sector, expecting steady growth in the coming quarters. The brokerage believes improving demand for treatments and stable operating trends will support performance. It has maintained a bullish view on key healthcare companies and also raised target prices for several stocks, highlighting strong future potential and consistent growth across the sector.

HSBC suggests that hospitals may see stable performance in Q4FY26. This is mainly because more patients are opting for planned treatments, known as elective procedures, which usually increase hospital revenues. Such procedures indicate improving demand and patient confidence, helping hospitals maintain steady growth during the quarter.

At the same time, hospitals are investing in new facilities, which can temporarily reduce profits due to higher costs. However, Apollo Hospitals is expected to handle this well and continue strong performance. Because of its consistent growth and efficient management, HSBC prefers Apollo Hospitals as a good investment option.

Here are a few Healthcare Stocks recommended by HSBC

Apollo Hospitals Enterprise Limited

With a market capitalization of Rs. 1,11,284.29 crore, the shares of Apollo Hospitals Enterprise Limited were currently trading at Rs. 7,739.65 per equity share, rising nearly 1.12 percent from its previous day’s close price of Rs. 7,653.85. 

HSBC, a prominent brokerage firm, has recommended a “Buy” call on Apollo Hospitals Enterprise Limited with an upgraded target price from Rs. 8750 to Rs. 9,000 per share, indicating an upside potential of 17.59 percent from its previous day’s close price of Rs. 7,653.85. 

Apollo Hospitals Enterprise Limited is India’s largest for‑profit private‑hospital network, headquartered in Chennai and founded in 1983. It operates a pan‑India chain of multi‑ and super‑specialty hospitals, diagnostic centres, pharmacies, tele‑health clinics, and digital‑health platforms, offering tertiary‑care services across oncology, cardiology, neurosciences, orthopaedics, organ transplants, and other specialties.

Max Healthcare Institute Limited

With a market capitalization of Rs. 99,226.71 crore, the shares of Max Healthcare Institute Limited were currently trading at Rs. 1,019.60 per equity share, rising nearly 0.92 percent from its previous day’s close price of Rs. 1,010.35. 

HSBC, a prominent brokerage firm, has recommended a “Buy” call on Max Healthcare Institute Limited with a target price of Rs. 1,125 per share, indicating an upside potential of 11.35 percent from its previous day’s close price of Rs. 1,010.35. 

Max Healthcare Institute Limited is a leading Indian private‑healthcare chain headquartered in Delhi, with a strong presence mainly in North India. It runs a network of multi‑specialty and super‑specialty hospitals, primary‑care clinics, pathology labs (Max Lab), and home‑care services, focusing on cardiology, oncology, nephrology, neurosciences, and women‑and‑child‑care, under a unified integrated‑care model.

Aster DM Healthcare Limited

With a market capitalization of Rs. 35,512.02 crore, the shares of Aster DM Healthcare Limited were currently trading at Rs. 685.40 per equity share, rising nearly 1 percent from its previous day’s close price of Rs. 678.60. 

HSBC, a prominent brokerage firm, has recommended a “Buy” call on Aster DM Healthcare Limited with an upgraded target price from Rs. 635 to Rs. 755 per share, indicating an upside potential of 11.26 percent from its previous day’s close price of Rs. 678.60. 

Aster DM Healthcare Limited is an Indian‑headquartered integrated healthcare‑services company founded in 1987, listed in India after separating its GCC business. It operates a wide network of hospitals, clinics, pharmacies, and diagnostic centres across Indian states and will merge with Quality Care India to form Aster DM Quality Care, offering primary, secondary, tertiary, and quaternary care, including digital‑health and medical‑education services.

Krishna Institute of Medical Sciences Limited

With a market capitalization of Rs. 27,249.46 crore, the shares of Krishna Institute of Medical Sciences Limited were currently trading at Rs. 681.00 per equity share, rising nearly 0.46 percent from its previous day’s close price of Rs. 677.90. 

HSBC, a prominent brokerage firm, has recommended a “Buy” call on Krishna Institute of Medical Sciences Limited with an upgraded target price from Rs. 750 to Rs. 780 per share, indicating an upside potential of 15.06 percent from its previous day’s close price of Rs. 677.90. 

Krishna Institute of Medical Sciences Limited (KIMS) is a fast‑growing multi‑specialty hospital chain founded in 2000 and listed on BSE and NSE, with a major footprint in Andhra Pradesh and Telangana. It provides primary, secondary, tertiary, and select quaternary‑care services through a network of hospitals in tier‑2 and tier‑3 cities, specialising in oncology, nephrology, cardiology, neurosciences, and minimally invasive surgeries.

Rainbow Childrens Medicare Limited

With a market capitalization of Rs. 12,892.93 crore, the shares of Rainbow Childrens Medicare Limited were currently trading at Rs. 1,269.50 per equity share, rising nearly 0.92 percent from its previous day’s close price of Rs. 1,246.60. 

HSBC, a prominent brokerage firm, has recommended a “Buy” call on Rainbow Childrens Medicare Limited with a target price of Rs. 1,400 per share, indicating an upside potential of 12.31 percent from its previous day’s close price of Rs. 1,246.60. 

Rainbow Childrens Medicare Limited is India’s largest dedicated paediatric and women‑health‑care hospital group, based in Hyderabad and founded in 1999. It operates a chain of multi‑specialty paediatric hospitals and obstetrics‑gynaecology facilities under the “Rainbow Children’s Hospital” and “Birthright by Rainbow” brands, offering neonatal and paediatric intensive care, transplants, and fertility‑care services across several Indian cities.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post 5 Healthcare Stocks to Buy for Your Portfolio; Recommended by HSBC appeared first on Trade Brains.